Considering the limited amount of IL-7 available in the bone marrow microenvironment [8,83], cells expressing a mutant IL7Rα would override the population of normal cells that express the wild type IL7Rα, contributing to leukemia progression. The gene discussed is IL7R; the disease is leukemia.